Literature DB >> 7374710

Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension.

A J Moss, W Glaser, E Topol.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7374710     DOI: 10.1056/NEJM198006263022606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Management of postural hypotension.

Authors:  M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Pathophysiological basis of orthostatic hypotension in autonomic failure.

Authors:  A A Smit; J R Halliwill; P A Low; W Wieling
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

3.  Pacing does not improve hypotension in patients with severe orthostatic hypotension--a prospective randomized cross-over pilot study.

Authors:  Zakir H Sahul; Jane M Trusty; Mark Erickson; Phillip A Low; Win-K Shen
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

4.  Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.

Authors:  J Goovaerts; C Verfaillie; R Fagard; D Knockaert
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

5.  Sympathetic nerve failure in diabetes.

Authors:  P J Watkins; M E Edmonds
Journal:  Diabetologia       Date:  1983-08       Impact factor: 10.122

6.  Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

7.  Long QT syndrome: how effective therapy in a single patient favorably influenced the long-term clinical course and genetic understanding of this hereditary disorder.

Authors:  Katherine M Lowengrub; Deborah R Moss; David A Moss; Arthur J Moss
Journal:  Prog Cardiovasc Dis       Date:  2015-08-04       Impact factor: 8.194

Review 8.  Chronic hypotension.

Authors:  I B Davies
Journal:  J R Soc Med       Date:  1982-08       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.